| 摘要 |
This invention provides an improved process for cis-1-{2-(4-(6-methoxy- 2- phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy)ethyl}pyrrolidine which is an intermediate for the preparation of (-)cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl- ethoxy)- phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol which is useful for the treatment of osteoporosis.
|
